Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.89
-0.10 (-1.67%)
At close: May 4, 2026, 4:00 PM EDT
6.07
+0.18 (3.06%)
After-hours: May 4, 2026, 5:32 PM EDT
Champions Oncology Revenue
Champions Oncology had revenue of $16.56M in the quarter ending January 31, 2026, a decrease of -2.82%. This brings the company's revenue in the last twelve months to $57.95M, down -1.10% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.
Revenue (ttm)
$57.95M
Revenue Growth
-1.10%
P/S Ratio
1.44
Revenue / Employee
$272,042
Employees
213
Market Cap
81.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 56.94M | 6.79M | 13.54% |
| Apr 30, 2024 | 50.16M | -3.72M | -6.90% |
| Apr 30, 2023 | 53.87M | 4.76M | 9.69% |
| Apr 30, 2022 | 49.11M | 8.07M | 19.66% |
| Apr 30, 2021 | 41.04M | 8.92M | 27.76% |
| Apr 30, 2020 | 32.12M | 5.06M | 18.68% |
| Apr 30, 2019 | 27.07M | 6.83M | 33.72% |
| Apr 30, 2018 | 20.24M | 4.83M | 31.34% |
| Apr 30, 2017 | 15.41M | - | - |
| Apr 30, 2016 | - | - | - |
| Apr 30, 2015 | - | - | - |
| Apr 30, 2014 | - | - | - |
| Apr 30, 2013 | - | - | - |
| Apr 30, 2012 | - | - | - |
| Apr 30, 2011 | - | - | - |
| Apr 30, 2010 | - | - | - |
| Apr 30, 2009 | 3.71M | 2.31M | 165.00% |
| Apr 30, 2008 | 1.40M | - | - |
| Apr 30, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gossamer Bio | 48.47M |
| Pelthos Therapeutics | 16.80M |
| Alterity Therapeutics | 4.43M |
| aTyr Pharma | 190.00K |
| eXoZymes | -700.00 |
CSBR News
- 25 days ago - Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 - Accesswire
- 5 weeks ago - Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - Accesswire
- 7 weeks ago - Champions Oncology Earnings Call Transcript: Q3 2026 - Transcripts
- 7 weeks ago - Champions Oncology Reports Revenue of $16.6 Million - Accesswire
- 2 months ago - Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 - Accesswire
- 5 months ago - Champions Oncology Earnings Call Transcript: Q2 2026 - Transcripts
- 5 months ago - Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million - Accesswire
- 5 months ago - Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025 - Accesswire